Literature DB >> 7417038

Exacerbations, activity, and progression in multiple sclerosis.

C M Poser.   

Abstract

The introduction of evoked response studies has disclosed the presence of asymptomatic lesions in multiple sclerosis (MS). This also raises an important question regarding the actual date of onset of the disease and the concept of disease activity. Close study of clinical exacerbations reveals that the recurrences of previously experienced symptoms are considerably more common than the appearance of new ones, and emphasizes the major role of physiologic and psychophysiologic alterations on the clinical course of the disease. The common practice of relating disease process activity to clinical symptoms is questioned in view of the nature of exacerbations and the poor anatomical correlation between demonstrable areas of activity revealed by radionuclide and contrast-enhanced CT scans and the patient's signs and symptoms. Symptomatic progression of MS may be due, in part, to relatively minor and subtle metabolic alterations of the interior millieu affecting the function of a nervous system with increased vulnerability.

Entities:  

Mesh:

Year:  1980        PMID: 7417038     DOI: 10.1001/archneur.1980.00500570019001

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  10 in total

1.  Predictive value of lesions for relapses in relapsing-remitting multiple sclerosis.

Authors:  J A Koziol; S Wagner; D F Sobel; L S Slivka; J S Romine; J C Sipe; H P Adams
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

2.  Evaluation of evoked potentials and lymphocyte subsets as possible markers of multiple sclerosis: one year follow up of 30 patients.

Authors:  A Ghezzi; M Zaffaroni; D Caputo; R Montanini; C L Cazzullo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

Review 3.  Pathogenesis of multiple sclerosis. A critical reappraisal.

Authors:  C M Poser
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

4.  The influence of disease activity on the number of blood cells of multiple sclerosis patients.

Authors:  U Patzold; U Wurster; K Mardt; M Schiemann
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

5.  Visual evoked potentials and CSF IgG at different stages of multiple sclerosis: a possible correlation.

Authors:  R Capparelli; D Inzitari; L Amaducci; D Baroncelli; M C Boschi; R Frosini
Journal:  Ital J Neurol Sci       Date:  1983-12

6.  Cranial computed tomography in the diagnosis of multiple sclerosis.

Authors:  L A Loizou; E B Rolfe; H Hewazy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-10       Impact factor: 10.154

7.  Serum testosterone, testicular connective tissue protein and testicular histology in rats treated with hyperbaric oxygen.

Authors:  T Nakada; H Saito; K Ota; T Saegusa; M Chikenji; T Matsushita
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

8.  Trauma and multiple sclerosis. An hypothesis.

Authors:  C M Poser
Journal:  J Neurol       Date:  1987-04       Impact factor: 4.849

9.  Magnetic resonance imaging and cognitive functioning in multiple sclerosis.

Authors:  R Medaer; E Nelissen; B Appel; M Swerts; J Geutjens; H Callaert
Journal:  J Neurol       Date:  1987-12       Impact factor: 4.849

10.  Multiple sclerosis: failure of treatment with verapamil in a pilot trial.

Authors:  S Komoly; G Jakab; A Fazekas
Journal:  J Neurol       Date:  1986-02       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.